News and Announcements
Altech Chemicals Limited Announced the Approval of Application for Meckering Kaolin Deposit
- Published August 31, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Altech Chemicals Limited (ASX:ATC) has recently announced the approval of application for screening and loading facility at the Company’s Meckering kaolin deposit was granted by the Western Australia Department of Water and Environment Regulation.
KEY TAKEAWAYS:
- Works approval granted by WA Department of Water and Environmental Regulation
- Construction of kaolin screen and loading facility at Meckering approved
- Works include ROM stockpile, evaporation pond, trammel screening unit, and loading facility
- Mining approval for Meckering previously received
- Meckering kaolin mining and processing now fully permitted to proceed, subject to funding
Commenting on the approval of works, managing director Mr Iggy Tan said, “We are pleased to receive notification of the approval of works for the kaolin screening and loading facility at Meckering, which will provide feedstock for the Company’s proposed Malaysian HPA processing plant. The Altech team has been working hard to advance all approvals required for Meckering, and this has now been achieved. This means that subject to funding, construction and mining operations at Meckering can commence.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
